Public Company News

Fibocom Introduces Pioneering OpenCPU Solution for 5G FWA, Built with R16-Compliant Module

Fibocom introduces pioneering OpenCPU solution for 5G FWA, built with the R16-compliant module FG160. The solution significantly accelerates product development process while meeting customers' expectations on cost, power consumption as well as security. SHENZHEN, China, April 15, 2022 /PRNewswi...

2022-04-15 16:00 5602

WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC

SINGAPORE, April 14, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global Contract Research, Development and Manufacturing Organization (CRDMO) service company, today announced that the company received the award for Bioprocessing Excellence in Viral Clearance and Safety at the A...

2022-04-15 09:03 2914

HUANENG POWER INTERNATIONAL, INC. DOMESTIC ON-GRID ELECTRICITY IN THE FIRST QUARTER OF 2022 INCREASED BY 2. 42% YEAR-ON-YEAR

BEIJING, April 14, 2022 /PRNewswire/ -- Huaneng Power International, Inc. ("HPI", the "Company") (NYSE: HNP; HKEx: 902; SSE: 600011) today announced its on-grid electricity for the first quarter of 2022. According to the preliminary statistics of the Company, for the first quarter of 2022, the C...

2022-04-14 23:40 2586

Asieris Pharmaceuticals Announces 2021 Annual Report: Steady Progress in Core Product Pipeline and Progressive Implementation of the Integrated Diagnosis and Treatment Commercialization Strategy

SHANGHAI, April 14, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176.SH), a global innovative pharmaceutical company specializing in the treatment of genitourinary cancers and related major diseases, announced its 2021 annual report today. The company is currently making steady progress in mu...

2022-04-14 22:49 3609

Zhihu Inc. Announces Pricing of Global Offering

BEIJING, April 14, 2022 /PRNewswire/ -- Zhihu Inc. (NYSE: ZH) ("Zhihu" or the "Company"), the operator of Zhihu, a leading online content community inChina, today announced the pricing of the global offering (the "Global Offering") of 26,000,000 Class A ordinary shares of the Company (the "Sale S...

2022-04-14 21:27 5182

Gracell Biotechnologies' Abstract on GC012F, a BCMA/CD19 Dual-targeting CAR-T Cell Therapy, Accepted for Presentation at 2022 ASCO Annual Meeting

PALO ALTO, Calif. and SUZHOU, China, April 14, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...

2022-04-14 20:30 3038

Ambow Receives MoE Approval for 174 University Collaborative Projects

BEIJING, April 14, 2022 /PRNewswire/ -- Ambow Education Holding Ltd. ("Ambow" or the "Company") (NYSE American: AMBO), a leading cross-border career educational and technology service provider, today announced that 174 of its university collaboration projects were listed in the Approved Projects ...

2022-04-14 20:30 2570

The Push for Glory Continues as Color Star's partner team Villarreal CF advances to the Semi-Finals of the UEFA Champions League

  NEW YORK, April 14, 2022 /PRNewswire/ -- Color Star Technology Co., Ltd. (Nasdaq: CSCW) ("Color Star" or the "Company"), an entertainment technology company with a global network that focuses on the application of technology and artificial intelligence in the entertainment industry, announces ...

2022-04-14 20:30 2700

China Medical System (0867.HK): the Leader in Commercialization Embraces Great Industry Opportunities as Biotech Companies are Eager to Monetize Their Innovative Products

HONG KONG, April 14, 2022 /PRNewswire/ -- Recently, China Medical System ("CMS", 0867.HK) announced its annual results. After recording continuous performance growth in the difficult time of the pandemic in 2020, it once again achieved a new record high, with revenue ofRMB 8,337 million, up 20.0%...

2022-04-14 20:24 2216

Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control

SHANGHAI, April 14, 2022 /PRNewswire/ -- April 13, 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH, 02196.HK) announced that the Novel Coronavirus (2019-nCoV) Antigen Detection Kit (Colloidal Gold) self-developed by Fosun Diagnostics Co....

2022-04-14 19:45 3515

Sharing Economy Appoints Jefferson Chan as Chairman and CEO

HONG KONG, April 14, 2022 /PRNewswire/ -- Sharing Economy International Inc. ("SEII") (OTCQB: SEII), announced today that the board of directors has appointed Mr.Pak Hei Jefferson Chan to be the Chairman and CEO, after Mr. Anthony Che Chung Chan has resigned as Chairman and CEO. Mr. Jefferson Ch...

2022-04-14 19:20 6024

MTU Yuchai Power Announces Major Production Milestone

SINGAPORE, April 14, 2022 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company") a leading manufacturer and distributor of engines for on- and off-road applications inChina through its main operating subsidiary, Guangxi Yuchai Machinery Company Limited ("...

2022-04-14 18:00 3222

CBAK Energy Reports Fourth Quarter and Full Year 2021 Unaudited Financial Results

--Net Revenues up 80% year over year in the fourth quarter – --Full-Year Net Revenues up 40% year over year in 2021– --CBAK Energy turns to profitability in 2021 DALIAN, China, April 14, 2022 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company") a leading ...

2022-04-14 17:30 4895

Qudian Inc. Announces Strategic Business Initiative

- Launching Ready-to-Cook Meal Business Nationwide - XIAMEN, China, April 14, 2022 /PRNewswire/ -- Qudian Inc. ("Qudian" or the "Company") (NYSE: QD), a consumer-oriented technology company in China, today announced it has launched a new strategic business initiative in ready-to-cook meals, or Q...

2022-04-14 17:00 5792

iQIYI Announces Changes to Board Composition

BEIJING, April 14, 2022 /PRNewswire/ -- iQIYI, Inc. (Nasdaq: IQ) ("iQIYI" or the "Company"), an innovative market-leading online entertainment service in China, today announced changes to its board composition. Mr. Conor Chia-hung Yang, has been appointed as an independent director of the board of...

2022-04-14 17:00 2865

Onion Global Announces Upgraded "Supply-to-Business" Strategy Integrating Upstream Supply Chain and Expanding B2B Customer Base

GUANGZHOU, China, April 14, 2022 /PRNewswire/ -- Onion Global Limited ("Onion Global", the "Group" or the "Company") (NYSE: OG), a next-generation lifestyle brand platform that incubates, markets, and distributes the world's fresh, fashionable, and future brands to young people inChina and across...

2022-04-14 16:00 4551

Akeso Publishes Preclinical Results of PD-1/LAG-3 Bi-specific Antibody(AK129)at the American Association for Cancer Research (AACR) 2022 Annual Meeting

HONG KONG, April 14, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced the publication of preclinical results of its PD-1/LAG-3...

2022-04-14 15:39 2728

Akeso Publishes Preclinical Results of PD-1/CD73 Bi-specific Antibody(AK131)at the American Association for Cancer Research (AACR) 2022 Annual Meeting

HONG KONG, April 14, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced the publication of preclinical results of its PD-1/CD73 ...

2022-04-14 15:05 2415

Akeso Publishes Preclinical Results of TIGIT monoclonal antibody(AK127)at the American Association for Cancer Research (AACR) 2022 Annual Meeting

HONG KONG, April 14, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced the publication of preclinical results of its anti-TIGIT...

2022-04-14 14:54 2635

Harbour BioMed Appoints Dr. Humphrey Gardner as Chief Medical Officer

CAMBRIDGE, Mass., SUZHOU, China and ROTTERDAM, Netherlands, April 13, 2022 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), today announced the appointment of Dr.Humphrey Gardner as Chief Medical Officer (CMO). Dr. Gardner will be responsible for leading the global product d...

2022-04-14 08:46 2299
1 ... 639640641642643644645 ... 759

Week's Top Stories